Matinas BioPharma Holdings annual operating margin
2015
2017
2018
2019
2020
2021
2022
2023
Matinas BioPharma Holdings Operating Margin Growth & History (MTNB)
Matinas BioPharma Holdings's operating margin was −2,168.43% for fiscal 2023.
View full Matinas BioPharma Holdings company overviewMatinas BioPharma Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −2,168.43% | −1397.10 pp |
| 2022 | 2022-12-31 | −771.33% | +74183.22 pp |
| 2021 | 2021-12-31 | −74,954.55% | −59666.16 pp |
| 2020 | 2020-12-31 | −15,288.38% | +5779.00 pp |
| 2019 | 2019-12-31 | −21,067.38% | −8836.45 pp |
| 2018 | 2018-12-31 | −12,230.94% | −1206.33 pp |
| 2017 | 2017-12-31 | −11,024.61% | −5928.56 pp |
| 2015 | 2015-12-31 | −5,096.04% | — |
Matinas BioPharma Holdings quarterly operating margin
Q1.15
Q2.15
Q3.15
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q2.19
Q3.20
Q1.21
Q2.22
Q3.22
Q1.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2023 | 2023-03-31 | −509.67% | +5338.63 pp |
| Q3 2022 | 2022-09-30 | −513.83% | +4519.66 pp |
| Q2 2022 | 2022-06-30 | −557.38% | +2731.94 pp |
| Q1 2021 | 2021-03-31 | −19,059.52% | −15268.38 pp |
| Q3 2020 | 2020-09-30 | −5,848.30% | +7916.43 pp |
| Q2 2019 | 2019-06-30 | −5,033.49% | +5278.22 pp |
| Q3 2018 | 2018-09-30 | −3,289.32% | +4300.53 pp |
| Q2 2018 | 2018-06-30 | −3,791.13% | +5063.59 pp |
| Q1 2018 | 2018-03-31 | −13,764.74% | +16212.04 pp |
| Q4 2017 | 2017-12-31 | −10,311.72% | −6705.23 pp |
| Q3 2017 | 2017-09-30 | −7,589.85% | −4470.64 pp |
| Q2 2017 | 2017-06-30 | −8,854.73% | −4398.10 pp |
| Q1 2017 | 2017-03-31 | −29,976.78% | — |
| Q3 2015 | 2015-09-30 | −3,606.48% | — |
| Q2 2015 | 2015-06-30 | −3,119.21% | — |
| Q1 2015 | 2015-03-31 | −4,456.62% | — |
Matinas BioPharma Holdings operating margin trends
Over the last five reported fiscal years, Matinas BioPharma Holdings's operating margin increased from −12,230.94% to −2,168.43%, a change of +10062.50 percentage points. The latest reported quarter, Q1 2023, shows −509.67%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Matinas BioPharma Holdings filings at SEC.gov ↗